The co-founders of BioNTech, married couple, Professors Ugur Sahin and Özlem Türec, today (10 March) announced plans to step down from BioNTech leadership roles and establish...
On 23 August, the Commission authorized the mRNA vaccine ‘mResvia', to immunise adults over 60 years of age against lower respiratory tract disease, which is caused by respiratory syncytial...
The European Investment Bank (EIB) and CureVac, a biopharmaceutical company developing innovative medicines based on optimized messenger ribonucleic acid (mRNA), entered into a €75 million loan...
German biopharmaceutical company CureVac GmbH has won the EU's first-ever innovation inducement prize. The company received the prize for progress towards a novel technology to bring...
